Scientific Advisory Board

Fausto J. Pinto, MD, Ph.D

FESC, FACC, FSCAI, FASE

Prof. Fausto Pinto graduated at Lisbon University Medical School in 1984. He did his Cardiology internship at Santa Maria University Hospital – CHLN, E.P.E. (Lisbon, Portugal), and Stanford University Medical School (CA, USA), where he was a Research Fellow and then Clinical Attending in the Echocardiography laboratory. He was also awarded with an Interventional Cardiology Fellowship at the same institution. He obtained his PhD at Lisbon University Medical School, in December 1993, and his Aggregation in 1997 by the same University.

He is currently Dean of the Faculty of Medicine of the University of Lisbon (since 2015), and Full Professor of Cardiology (since 2010). He is also the Head of the Cardiology Department (since 2014) and of the Heart and Vessels Department (since 2016) of Santa Maria University Hospital, CHULN E.P.E.. Additionally, he is the President of the Medical Schools Council (2018-2020) and President of the Executive Board of the Lisbon Academic Medical Centre (CAML) (2019-2021). He was the President of the Associação para Investigação e Desenvolvimento da Faculdade de Medicina between 2003 and 2015.

He was nominated President Elect of the World Heart Federation (WHF) (2019-2020), and Director of the European Society of Cardiology (ESC) (2014-16), the only Portuguese to have been elected to these leadership positions in Cardiovascular Medicine. He was Chairman of the ESC Echocardiography Working Group (2000-2002 as Vice-Chairman) and after he was the President and founder of the European Association of Echocardiography (2003-04). He was elected Councillor of the ESC Board (2004-06), ESC Board Member (2007-2010), ESC Vice-President (2010-2012) and ESC President (2012-2014). He has held various positions in different scientific institutions, being an honorary member or fellow of several of them, including Fellow of the American College of Cardiology (FACC), Gold Medalist and Fellow of the ESC (FESC), The Society for Cardiovascular Angiography and Interventions (FSCAI), American Society of Angiology (FASA), Honorary Fellow of the American Society of Echocardiography (FASE), Societé Française de Cardiologie, Sociedade Romena de Cardiologia, Romanian Academy of Medical Sciences, Società Italiana di Ecografia Cardiovascolare (SIEC), Sociedad Colombiana de Cardiologia, Academia Nacional de Medicina do Brasil, Hungarian Society of Cardiology. Japanese Circulation Society, Sociedad Peruana de Cardiologia, Romanian Society of Cardiology, Russian Society of Cardiology, Slovakian Society of Cardiology, Ukranian Society of Cardiology. He was awarded several prizes and distinctions, including, more recently, in 2019, the International Service Award of the American College of Cardiology (ACC). He is Doctor Honoris Causa of the Semmelweis University, Budapest, Hungria.

He was the Editor in Chief of the Portuguese Journal of Cardiology (1999-2015), and is currently Consulting Editor and Member of the Advisory and Editorial of Board of several international peer-reviewed journals.

Prof. Pinto has participated in several national and international studies, including the FP7 and Horizon 2020 European Programmes, as National Coordinator of several of these studies. He has published over 500 indexed articles (h=51) and has presented over 1500 lectures/chairmanships at national and mostly international meetings.

www.faustopinto.com

Dulce Brito, MD, Ph.D

FESC

Cristina has PharmD from the University of Lisbon. Additionally, she attended 3 years in Medicine at Universidade Nova de Lisboa.

September 2019 Cristina joined Takeda Portugal as Patient Advocacy Group Manager & Clinical
Operations Manager, where she is currently responsible for the coordination of services related to
patient care, access to research and communication of evidence and support patient organizations related to the diseases that Takeda is involved. Supports Medical Affairs in the planning and execution of local research, namely, Real World Evidence (RWE) and Investigator Initiated Studies (IIS).

During 6 years, Cristina was a Clinical Research Associate in the pharmaceutical industry where she was responsible for the monitoring of several phase IIa, IIb and III trials in psychiatry, neurology, oncology and in cardiovascular diseases. Later in 2013, and during 5 years, Cristina was Clinical Operations Manager and CRO Manager at Servier where she was responsible for the management of several phase IIa, IIb and III trials in cardiovascular diseases, osteoarthrosis, diabetic kidney disease and oncology.

Since April 2017 Cristina worked as Clinical Operations Country Study Manager and Study Start-up Specialist at Roche, being responsible for the implementation of several phase II and III clinical trials in prostate and breast cancer.

Cristina joined the CETERA team as an External Consultant, participating in training programs.

Cristina Valente, PharmD

Cristina has PharmD from the University of Lisbon. Additionally, she attended 3 years in Medicine at Universidade Nova de Lisboa.

September 2019 Cristina joined Takeda Portugal as Patient Advocacy Group Manager & Clinical Operations Manager, where she is currently responsible for the coordination of services related to patient care, access to research and communication of evidence and support patient organizations related to the diseases that Takeda is involved. Supports Medical Affairs in the planning and execution of local research, namely, Real World Evidence (RWE) and Investigator Initiated Studies (IIS).

During 6 years, Cristina was a Clinical Research Associate in the pharmaceutical industry where she was responsible for the monitoring of several phase IIa, IIb and III trials in psychiatry, neurology, oncology and in cardiovascular diseases. Later in 2013, and during 5 years, Cristina was Clinical Operations Manager and CRO Manager at Servier where she was responsible for the management of several phase IIa, IIb and III trials in cardiovascular diseases, osteoarthrosis, diabetic kidney disease and oncology. Since April 2017 Cristina worked as Clinical Operations Country Study Manager and Study Start-up Specialist at Roche, being responsible for the implementation of several phase II and III clinical trials in prostate and breast cancer.

Cristina joined the CETERA team as an External Consultant, participating in training programs.

Ricardo M. Fernandes, MD, Ph.D

Ricardo is an Attending Pediatrician at the Department of Pediatrics of Centro Hospitalar Universitário Lisboa Norte, and an Assistant Professor and a Clinical Researcher at the Clinical Pharmacology and Therapeutics Laboratory, Faculty of Medicine and Instituto de Medicina Molecular, University of Lisbon.

His research background includes clinical epidemiology, clinical trial methodology, outcome measurement and synthesis research, with training and fellowships in the Netherlands and Canada. His main clinical research interests are pediatric respiratory disease, allergy and emergency medicine, and his favored methodological topics include research on outcomes and measurement, clinical trial design, meta-analysis, knowledge translation, and clinical pharmacology, particularly in pediatrics.

He has been actively involved in a number of international research collaborations, including the StaR Child Health initiative on improving clinical trial research in pediatrics, the PERN (Pediatric Emergency Research Networks) worldwide academic clinical research network and the COMET initiative (Core Outcome Measures in Effectiveness Trials. He is particularly engaged in several activities within the Cochrane Collaboration, being a Co-Director of the Cochrane Child Health Field, and within the European Respiratory Society.

He is the project lead for STAND4Kids, the portuguese National Hub for the c4c Conect4Children IMI2 project, a pan-european clinical trial network.

You can follow him on ResearchGate (https://www.researchgate.net/profile/Ricardo_Fernandes4) and on Twitter (@DonDonRic).